Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 4111 AL 4125

Zonisamide-induced pleural effusion and agranulocytosis: a case report of a rare adverse reaction

Mimori M, Takatsu H, Omoto S.

Neurol Sci. 2026 Jan 3;47(1):89. doi: 10.1007/s10072-025-08593-x.

Commonalities in rehabilitation data across diverse health conditions: a comparison of seven large European databases

Kiekens C, Burger H, Capodaglio P, Ceravolo MG, Janssen E, Jurenaite G, Malfitano C, Pennestri F, Selles R, Tartaglia GM, Negrini S.

J Rehabil Med. 2026 Mar 23;58:jrm45495. doi: 10.2340/jrm.v58.45495.

Current potential biomarkers for Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis: review of literature

Peng J, Fan T, Wang J, Deng Y, Xu R.

Dialogues Clin Neurosci. 2026 Dec;28(1):17-39. doi: 10.1080/19585969.2026.2622722. Epub 2026 Feb 6.

Carbidopa/levodopa induced severe vitamin B6 deficiency leading to symptomatic transfusion dependent microcytic Anemia

Lee BK, Gastwirt JP.

Oxf Med Case Reports. 2026 Apr 28;2026(4):omaf191. doi: 10.1093/omcr/omaf191. eCollection 2026 Apr.

Limitations of Stem Cell Therapy for Parkinson's Disease

Li Z, Peng S, Ouyang J, Liu R.

Cells. 2026 May 3;15(9):839. doi: 10.3390/cells15090839.

Rise-and-fall dynamics reveal a molecular and cellular vulnerability axis in prion-like α-synuclein propagation

Alexandersen CG, Brynildsen JK, Prigent A, Tamborrino M, Mantziou A, Kurgat K, Henderson MX, Bassett DS.

bioRxiv [Preprint]. 2026 Mar 31:2026.03.27.714785. doi: 10.64898/2026.03.27.714785.

Parkinson's disease biomarkers: bridging the gap between diagnosis and treatment

Chakkarwar VA, Kulkarni YA.

Behav Brain Res. 2026 May 8;505:116120. doi: 10.1016/j.bbr.2026.116120. Epub 2026 Feb 21.

Vagus Nerve Stimulation in the Management of Neurodegenerative Diseases: A Systematic Review of Advances in Animal Research and Clinical Applications

Edelbach B, Huang L, Boling W.

Curr Alzheimer Res. 2026 Jan 21. doi: 10.2174/0115672050373772251103053036. Online ahead of print.

Assessment of mental and behavioural non-motor symptoms of Parkinson's Disease using Artificial Intelligence (AI): a systematic review

Chou SC, Cong C, Brownson-Smith R, Milne-Ives M, Meinert E.

Commun Med (Lond). 2026 Feb 9;6(1):101. doi: 10.1038/s43856-025-01304-9.

Unraveling the intersection of aging and Parkinson's disease: a collaborative roadmap for advancing research models

Schmidt MY, Cuervo AM, Double KL, Ehninger D, Goldberg MS, Harvey K, Hoeijmakers JHJ, Luk KC, Mastroberardino PG, Moore DJ, Niedernhofer LJ, Trudeau LÉ, Jurk D, Andersen JK, Bellantuono I.

NPJ Parkinsons Dis. 2026 Jan 16;12(1):28. doi: 10.1038/s41531-025-01239-x.

Body Fluid-based Biomarkers for Cognitive Impairment in Parkinson's Disease

R R, Choudhury S, N C K, Bharath MMS, Rathod BLS, Yadav R, Alladi PA.

Ann Neurosci. 2026 May 18:09727531261442666. doi: 10.1177/09727531261442666. Online ahead of print.

Systematic review of alpha-synuclein seed amplification assays for the detection of synucleinopathies

López-Bellido A, Marti-Navia A, Cháfer-Pericás C.

Clin Chim Acta. 2026 May 20;590:121101. doi: 10.1016/j.cca.2026.121101. Online ahead of print.

Micro- and nanoplastics influences in Parkinson's disease: lessons from human stem cell models

Muhammad KN, Woodlief T, Wu X.

Front Toxicol. 2026 Mar 26;8:1723092. doi: 10.3389/ftox.2026.1723092. eCollection 2026.

Interventions for preventing falls in older people in hospitals

McLennan C, Dyer SM, Kwok WS, Suen J, Marin TS, Haley M, Murray GR, Sutcliffe K, Kneale D, Sherrington C, Cameron ID.

Cochrane Database Syst Rev. 2026 May 5;5(5):CD016065. doi: 10.1002/14651858.CD016065.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias